Alembic Pharma gets USFDA nod for generic medication

The company has received final approval from the US Food Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Fesoterodine Fumarate extended-release tablets in strength of 4 mg and 8 mg, the drug firm said in a statement.